Steven M. Finegan

482 total citations
5 papers, 235 citations indexed

About

Steven M. Finegan is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Steven M. Finegan has authored 5 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 2 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Steven M. Finegan's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (2 papers) and Pneumonia and Respiratory Infections (2 papers). Steven M. Finegan is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (2 papers) and Pneumonia and Respiratory Infections (2 papers). Steven M. Finegan collaborates with scholars based in United States. Steven M. Finegan's co-authors include Craig J. McPherson, Andrew P. Tomaras, Michael W. Dunne, Mary E. Lame, D Girard, Matthew F. Brown, David P. Nicolau, Mary Anné Banevicius, John P. O’Donnell and Jared L. Crandon and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Steven M. Finegan

5 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven M. Finegan United States	4	125	88	82	47	43	5	235
S Kwan Malaysia	6	122 1.0×	138 1.6×	66 0.8×	20 0.4×	71 1.7×	6	301
Sivashangarie Sivanesan Australia	7	224 1.8×	95 1.1×	127 1.5×	62 1.3×	35 0.8×	7	327
Malin Kvist Sweden	4	153 1.2×	203 2.3×	45 0.5×	36 0.8×	20 0.5×	5	337
Amy Kutschke United States	10	150 1.2×	197 2.2×	68 0.8×	45 1.0×	37 0.9×	13	463
Lisa Aschenbrenner United States	7	74 0.6×	111 1.3×	33 0.4×	86 1.8×	37 0.9×	7	308
Irina Sánchez-Diener Spain	10	247 2.0×	145 1.6×	84 1.0×	41 0.9×	42 1.0×	10	301
Kenneth B. Wlasichuk Canada	6	154 1.2×	128 1.5×	105 1.3×	51 1.1×	15 0.3×	7	286
Arnaud Bolard France	6	363 2.9×	164 1.9×	111 1.4×	56 1.2×	71 1.7×	7	457
Lisa M. Leung United States	10	221 1.8×	168 1.9×	51 0.6×	57 1.2×	48 1.1×	10	424
M. Megan Lemmon United States	9	159 1.3×	135 1.5×	52 0.6×	39 0.8×	54 1.3×	12	347

Countries citing papers authored by Steven M. Finegan

Since Specialization

Citations

This map shows the geographic impact of Steven M. Finegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Finegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Finegan more than expected).

Fields of papers citing papers by Steven M. Finegan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Finegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Finegan. The network helps show where Steven M. Finegan may publish in the future.

Co-authorship network of co-authors of Steven M. Finegan

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Finegan. A scholar is included among the top collaborators of Steven M. Finegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Finegan. Steven M. Finegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Tomaras, Andrew P., Jared L. Crandon, Craig J. McPherson, et al.. (2013). Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 57(9). 4197–4207. 95 indexed citations

2.

McPherson, Craig J., Lisa Aschenbrenner, Brian M. Lacey, et al.. (2012). Clinically Relevant Gram-Negative Resistance Mechanisms Have No Effect on the Efficacy of MC-1, a Novel Siderophore-Conjugated Monocarbam. Antimicrobial Agents and Chemotherapy. 56(12). 6334–6342. 73 indexed citations

3.

Girard, D, Steven M. Finegan, Michael W. Dunne, & Mary E. Lame. (2005). Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models. Journal of Antimicrobial Chemotherapy. 56(2). 365–371. 57 indexed citations

4.

Okusanya, Ólanrewaju O., Alan Forrest, Brent M. Booker, et al.. (2005). Pharmacokinetics and pharmacodynamics of azithromycin in gerbils with haemophilus influenzae middle ear infection. Clinical Pharmacology & Therapeutics. 77(2). P89–P89. 1 indexed citations

5.

Lyssikatos, Joe, J. P. Clancy, John P. Dirlam, et al.. (1997). Cyclic homopentapeptides 2. Synthetic modifications of viomycin. Bioorganic & Medicinal Chemistry Letters. 7(9). 1145–1148. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact